As a leader in medical dermatology with a robust pipeline, a wide range of therapies, and a pioneering spirit, LEO Pharma's purpose is to make a true difference to the lives of people living with skin diseases.
LEO PHARMA UK AND IRELAND
WE HELP PEOPLE ACHIEVE HEALTHY SKIN
Established globally, LEO Pharma has a proven track record of pioneering solutions in treatment areas spanning, plaque psoriasis, atopic dermatitis, acne and actinic keratosis.
LEO Pharma is committed to helping 125 million people by 2025. As long as there is a patient out there needing our help, we carry on our mission.
LEO Pharma believes in developing powerful partnerships with a range of stakeholders in order to drive innovation; heighten education and improve patient outcomes.
We collaborate with the NHS, academic institutions, research centres, healthcare professionals and the private sector worldwide.
We view these relationships as driven by a shared commitment to look beyond today to constantly improve and extend what's possible for people living with skin conditions.
"LEO Pharma were instrumental in the formation of the Primary Care Dermatology Society back in 1994 and have supported the Society since that time."
- Siobhan Wastie, Commercial Director, Primary Care Dermatology Society (PCDS)
- Professor Rino Cerio, Consultant, Dermatologist, Barts Health NHS Trust
- Dr Anthony Bewley, Consultant Dermatologist, Barts Health NHS Trust
WE ARE PIONEERING
WE LOOK BEYOND TODAY TO CONSTANTLY IMPROVE AND EXTEND WHAT'S POSSIBLE FOR THE BENFIT OF PATIENTS
WE PUT PEOPLE LIVING WITH SKIN CONDITIONS
AT HEART OF EVERYTHING WE DO
We listen to people about the impact of living with the conditions we aim to treat. We involve patients at the early stages of our research and development programmes.
Through long-term relationships with a range of stakeholder groups, we strive to help healthcare professionals in the UK and Ireland deliver the best possible care for patients.
DERMATOLOGY BEYOND THE SKIN:
INITIATIVES THAT WE ARE PROUD OF...
The Voices in Partnership (ViP) programme, bringing together people living with skin conditions, so helping us to better understand the day-to-day impact of having a skin condition
Partnership with the Patients Association on the PSO What? Report raising awareness of the real impact psoriasis has on people's lives and gaps in continuity of care
Multi-award-winning campaign 'Give Nothing To Psoriasis', empowering those living with psoriasis to make positive changes and not to give up' aspects of their lie to the condition
20,000 visitors from the UK and Ireland to our QualityCareTM resource that provides support for people living with psoriasis each month
Industry Dermatology Initiative (IDI), LEO Pharma is part of a group of companies dedicated to working with the NHS to optimise the care of people living with conditions. The group exists to work collaboratively with stakeholders across the field of dermatology to complement existing work streams in this area
350,000 engagements with leo pharma social channels
LEO Pharma will continue to work relentlessly to further strengthen patient voices, develop our partnerships with patient advocacy, and support patients in getting access to the dermatology care they need. The collective skills and efforts from everyone at LEO Pharma and our partners are the basis for our success. We continue on the path we've chartered for more than 110 years -building, sharing and reinvesting in knowledge.
Let's pioneer together.
Twitter: @LEOPharmaUKIE Instagram: @leopharmaukie Facebook: Facebook.com/LEOPharmaUKIE YouTube: LEO Pharma UK/IE Email: email@example.com Quality CareTM: psoriasis.qualitycarebyleo.com Produced by LEO Pharma
October 2019 | UK/IE/MAT-25668